Skip to main content

Table 2 Comparison of initial laboratory findings, amount of blood transfusion, and clinical outcomes based on the presence of hypofibrinogenemia in patients with primary postpartum hemorrhage

From: Thromboelastography as an early prediction method for hypofibrinogenemia in emergency department patients with primary postpartum hemorrhage

Variables

Hypofibrinogenemia group

(n = 73)

No-hypofibrinogenemia group

(n = 101)

p value

Laboratory findings

 Lactate, mmol/L

2.3 (1.8–3.2)

2.2 (1.6–3.0)

0.138

 Hemoglobin, g/dL

8.7 (7.8–10.1)

10.9 (9.5–12.3)

< 0.001

 Hematocrit, %

27.6 (23.6–31.2)

32.3 (29.8–36.7)

< 0.001

 Platelet, × 103/uL

125 (103–146)

175 (148–214)

< 0.001

 PT (INR)

1.3 (1.2–1.6)

1.1 (1.0–1.1)

< 0.001

 FDP, ug/mL

120 (57–125)

34 (17–82)

< 0.001

 D-dimer, ug/mL

35.2 (11.8–35.5)

10.9 (5.8–25.4)

< 0.001

Amount of blood transfusion (units)

 Packed red blood cells

6.0 (4.0–11.0)

3.0 (1.0–5.0)

< 0.001

 Fresh frozen plasma

5.0 (3.0–10.0)

1.0 (0.0–4.0)

< 0.001

 Platelet concentrate

0.0 (0.0–8.0)

0.0 (0.0–0.0)

< 0.001

 Cryoprecipitate

0.0 (0.0–3.0)

0.0 (0.0–0.0)

0.008

Clinical outcome

 Massive transfusion

27 (37.0)

5 (5.0)

< 0.001

 Embolization

50 (68.5)

37 (36.6)

< 0.001

 Hysterectomy

1 (1.4)

1 (1.0)

1.000

 Length of hospital stay, days

2.0 (2.0–4.0)

2.0 (1.0–3.0)

0.003

 ICU admission

2 (2.7)

5 (5.0)

0.700

 In-hospital death

1 (1.4)

0 (0.0)

0.420

  1. Values are expressed as the median [interquartile range] or number (%)
  2. PT, prothrombin time; INR, international normalized ratio; FDP, fibrinogen degradation production; ICU, intensive care unit